Clinuvel Pharmaceuticals Ltd (OTC Pink - Current Information:CLVLY)

Add to Watch List

Set Alert

5.54 Delayed Data As of Oct 19	+0.24 / +4.53% Today’s Change	4.67 Today\|\|\|52-Week Range 6.92	+4.73% Year-to-Date

5.54

Delayed Data

As of Oct 19

+0.24 / +4.53%

Today’s Change

4.67

Today|||52-Week Range

6.92

+4.73%

Year-to-Date

SECTOR

Health Technology

INDUSTRY

Pharmaceuticals: Other

MARKET CAP

$253.0M

Company Description

Clinuvel Pharmaceuticals Ltd. operates as a global biopharmaceutical company, which is focused on the development of SCENESSE, its proprietary photoprotective drug. It also focuses on developing drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia.

Contact Information

Clinuvel Pharmaceuticals Ltd.

190 Queen Street

Melbourne Victoria (vic) 3000

P:(139) 660-4900

Investor Relations:

www.clinuvel.com

Employees

Shareholders

Mutual fund holders	--
Individual stakeholders	--
Other institutional	--

Top Executives